Drug Delivery Device for Age-Related Macular Degeneration (AMD)
Karl G. Csaky, M.D., Ph.D., Director, Molecular Ophthalmology Laboratory, is working with his research team to develop a drug delivery device for patients with age-related macular degeneration (AMD). It is a small Polymer device that slowly releases therapeutic drugs as needed over a period of weeks, months or years as prescribed by your physician. The device is placed on the outer part of the eye and does not interfere with patient vision or comfort. The device can remain in place for a long period of time as prescribed by the physician care team. Placement of the implant on the surface of the eye, rather than inside the eye, allows for long-term drug delivery to the eye. This innovative drug delivery device allows physicians to administer medication delivery in a less invasive way, and better manage the disease.
Related ArticlesThe Effectiveness of Therapeutic Drugs for AMD in the Laboratory The Rosewood Foundation And Retina Foundation Of The Southwest Partner Up Again For “Keeping An Eye On Innovation” Series Retina Foundation Presents New Data & Conclusions at ARVO 2018 iPad Games Could Be the Future Lazy Eye Treatment Meet Sharon and Harold Hosack